Predictors of postpartum diabetes in women with gestational diabetes mellitus

被引:173
作者
Löbner, K
Knopff, A
Baumgarten, A
Mollenhauer, U
Marienfeld, S
Garrido-Franco, M
Bonifacio, E
Ziegler, AG
机构
[1] Krankenhaus Munchen Schwabing, Diabet Res Inst, Munich, Germany
[2] Krankenhaus Munchen Schwabing, Dept Med 3, Munich, Germany
[3] Ist Sci San Raffaele, Immunol Diabet Unit, I-20132 Milan, Italy
关键词
D O I
10.2337/diabetes.55.03.06.db05-0746
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to stratify risk for postpartum diabetes in women who have gestational diabetes. Women with gestational diabetes were recruited between 1989 and 1999, and 302 were followed with oral glucose tolerance tests at 9 months and 2, 5, 8, and 11 years postpregnancy. The 8-year postpartum diabetes risk was 52.7% (130 diabetic cases). Risk was increased in women with autoantibodies to GAD and/or insulinoma antigen-2 (adjusted hazard ratio 4.1; P < 0.0001), women who required insulin during pregnancy (4.7; P < 0.0001), women with BMI >30 kg/m(2) (1.5; P = 0.04), and women with more than two prior pregnancies (2.5; P = 0.02). Women without these risk factors had a postpartum diabetes risk of 14% by 8 years, and risk rose incrementally to 96% by 8 years in autoantibody-positive women. Parity status, C-reactive protein concentration, a diabetes family history, maternal age, weeks of gestation, and the child's birth weight did not significantly affect risk in multivariate analysis. Prospective diabetes assessment is indicated and intervention should be considered in women with gestational diabetes who are autoantibody positive, require insulin treatment during pregnancy, or are obese.
引用
收藏
页码:792 / 797
页数:6
相关论文
共 31 条
[1]   Predictive factors of developing diabetes mellitus in women with gestational diabetes [J].
Åberg, AEB ;
Jönsson, EK ;
Eskilsson, I ;
Landin-Olsson, M ;
Frid, AH .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (01) :11-16
[2]  
[Anonymous], 2005, DIABETES CARE, V28, pS4
[3]   TRIPOD (TRoglitazone in the Prevention of Diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus [J].
Azen, SP ;
Peters, RK ;
Berkowitz, K ;
Kjos, S ;
Xiang, A ;
Buchanan, TA .
CONTROLLED CLINICAL TRIALS, 1998, 19 (02) :217-231
[4]   Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes [J].
Ben-Haroush, A ;
Yogev, Y ;
Hod, M .
DIABETIC MEDICINE, 2004, 21 (02) :103-113
[5]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[6]   Elevated C-reactive protein levels in the development of type 1 diabetes [J].
Chase, HP ;
Cooper, S ;
Osberg, I ;
Stene, LC ;
Barriga, K ;
Norris, J ;
Eisenbarth, GS ;
Rewers, M .
DIABETES, 2004, 53 (10) :2569-2573
[7]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[8]   PREVALENCE AND PREDICTIVE VALUE OF ISLET-CELL ANTIBODIES AND INSULIN AUTOANTIBODIES IN WOMEN WITH GESTATIONAL DIABETES [J].
DAMM, P ;
KUHL, C ;
BUSCHARD, K ;
JAKOBSEN, BK ;
SVEJGAARD, A ;
SODOYEZGOFFAUX, F ;
SHATTOCK, M ;
BOTTAZZO, GF ;
MOLSTEDPEDERSEN, L .
DIABETIC MEDICINE, 1994, 11 (06) :558-563
[9]   Inflammation: the link between insulin resistance, obesity and diabetes [J].
Dandona, P ;
Aljada, A ;
Bandyopadhyay, A .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :4-7
[10]  
Diabetes Prevention Progam, 2005, DIABETES, V54, P1150